| | Business Summary | | BioReliance
Corporation
is
a
contract
service
organization
that
provides
testing
and
development
and
manufacturing
services
for
biologics
and
other
biomedical
products
to
biotechnology
and
pharmaceutical
companies
worldwide.
Through
its
testing
and
development
business
segment,
the
Company
evaluates
products
to
ensure
that
they
are
free
of
disease-causing
agents
or
do
not
cause
adverse
effects,
characterizes
products'
chemical
structures,
develops
formulations
for
long-term
stability
and
validates
purification
processes
under
regulatory
guidelines.
In
its
manufacturing
business
segment,
BioReliance
develops
production
processes
and
manufactures
biologics
on
behalf
of
clients,
both
for
use
in
clinical
trials
and
for
the
worldwide
commercial
market. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | BioReliance
is
a
contract
research
organization
providing
nonclinical
testing
and
contract
manufacturing
services
for
biologics
to
biotechnology
and
pharmaceutical
companies
worldwide.
For
the
six
months
ended
6/30/01,
revenues
rose
16%
to
$31.6
million.
Net
income
totaled
$1.3
million,
up
from
$456
thousand.
Results
reflect
increased
rates
of
new
orders,
higher
biosafety
testing
services
and
texicology
services
sales
and
lower
restructuring
charges. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Sidney Knafel, 70
Chairman | -- | Capers McDonald, 49
Pres,
CEO, Director | $515K | John Coker, 54
CFO,
VP of Fin. and Admin., Treasurer | -- | Ronald Baker, 50
VP
of Sales and Marketing | -- | Raymond Cosgrove, Ph.D., 53
VP,
European Operations | -- | | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/b/brel.gif)